DK3449955T3 - Fremstilling af skalerbart tredimensionelt elastisk konstrukt - Google Patents

Fremstilling af skalerbart tredimensionelt elastisk konstrukt Download PDF

Info

Publication number
DK3449955T3
DK3449955T3 DK18188002.2T DK18188002T DK3449955T3 DK 3449955 T3 DK3449955 T3 DK 3449955T3 DK 18188002 T DK18188002 T DK 18188002T DK 3449955 T3 DK3449955 T3 DK 3449955T3
Authority
DK
Denmark
Prior art keywords
scalable
manufacture
elastic construction
dimensional elastic
dimensional
Prior art date
Application number
DK18188002.2T
Other languages
English (en)
Inventor
Anthony Steven Weiss
Suzanne Marie Mithieux
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012905409A external-priority patent/AU2012905409A0/en
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Application granted granted Critical
Publication of DK3449955T3 publication Critical patent/DK3449955T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
    • B05D3/007—After-treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
DK18188002.2T 2012-12-10 2013-12-10 Fremstilling af skalerbart tredimensionelt elastisk konstrukt DK3449955T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012905409A AU2012905409A0 (en) 2012-12-10 Scalable three-dimensional elastic construct manufacturing
EP13863652.7A EP2928512B1 (en) 2012-12-10 2013-12-10 Scalable three-dimensional elastic construct manufacturing

Publications (1)

Publication Number Publication Date
DK3449955T3 true DK3449955T3 (da) 2021-01-18

Family

ID=50933572

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13863652.7T DK2928512T3 (da) 2012-12-10 2013-12-10 Skalerbar fremstilling af tredimensionelle elastiske konstruktioner
DK18188002.2T DK3449955T3 (da) 2012-12-10 2013-12-10 Fremstilling af skalerbart tredimensionelt elastisk konstrukt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13863652.7T DK2928512T3 (da) 2012-12-10 2013-12-10 Skalerbar fremstilling af tredimensionelle elastiske konstruktioner

Country Status (12)

Country Link
US (3) US10842913B2 (da)
EP (3) EP2928512B1 (da)
JP (3) JP6401178B2 (da)
KR (2) KR102398811B1 (da)
CN (1) CN105246520B (da)
AU (1) AU2013360011B2 (da)
BR (1) BR112015013627A2 (da)
CA (1) CA2933047A1 (da)
DK (2) DK2928512T3 (da)
ES (2) ES2702602T3 (da)
RU (1) RU2668877C2 (da)
WO (1) WO2014089610A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
AU2014306362B2 (en) 2013-08-13 2019-04-18 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
KR101809929B1 (ko) 2015-05-08 2017-12-18 충남대학교 산학협력단 칼슘결합 단백질 및 이에 의해 형성된 코아세르베이트
US10736942B2 (en) 2015-09-01 2020-08-11 Allergan Pharmaceuticals International Limited Formation of bone
US20190275204A1 (en) * 2016-11-04 2019-09-12 Elastagen Pty Ltd Biosynthetic devices
WO2019006430A1 (en) * 2017-06-30 2019-01-03 Vascudyne Inc REGENERATIVE FABRIC IMPLANTS AND NATURAL TISSUE
US11648135B2 (en) 2017-09-13 2023-05-16 Boston Scientific Scimed, Inc. Coated stent
US11178934B2 (en) * 2018-07-18 2021-11-23 Bolt Threads Inc. Resilin material footwear and fabrication methods
EP4076555A1 (en) * 2019-12-18 2022-10-26 Allergan Pharmaceuticals International Limited Hybrid polymeric materials and uses thereof
MX2022009004A (es) * 2020-02-06 2022-10-20 Allergan Pharmaceuticals Int Ltd Andamios de ingenieria de tejidos.
US20210308336A1 (en) * 2020-04-03 2021-10-07 Lifecell Corporation Adipose tissue matrix with tropoelastin
CN114146232B (zh) * 2022-02-10 2022-04-19 天新福（北京）医疗器材股份有限公司 一种抗菌异构多孔膜及其制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US4667486A (en) 1986-05-05 1987-05-26 General Electric Company Refrigerated penetration insert for cryostat with axial thermal disconnect
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
KR0184860B1 (ko) 1988-11-11 1999-04-01 메디칼 리써어치 카운실 단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법)
CA2057014C (en) 1990-03-30 2001-07-24 Toshihiko Kaminuma Process for purification of polypeptide
US5844094A (en) 1992-09-25 1998-12-01 Commonwealth Scientific And Industrial Research Organization Target binding polypeptide
DE69334243D1 (de) 1992-12-22 2008-12-04 Univ Sydney Synthetische polynukleotide
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
AUPO156596A0 (en) 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
WO1998034563A1 (en) 1997-02-07 1998-08-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US20030190669A1 (en) 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6667051B1 (en) 1999-05-28 2003-12-23 Kenton W. Gregory Methods for producing elastin, and tropoelastin products for repairing and or replacing tissue
ES2491866T3 (es) 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
JP4214051B2 (ja) * 2001-05-30 2009-01-28 啓一 宮本 エラスチン架橋体およびその製造方法
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
WO2005060396A2 (en) * 2003-08-18 2005-07-07 The General Hospital Corporation Nanotopographic compositions and methods for cellular organization in tissue engineered structures
US7666829B2 (en) 2004-02-20 2010-02-23 Human Matrix Sciences, Llc Compositions for elastogenesis and connective tissue treatment
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
EP1945144A4 (en) 2005-10-19 2012-12-05 Kenton W Gregory PROCESS FOR THE USE AND PRODUCTION OF TROPOELASTIN AND BIOMATERIALS BASED ON TROPOELASTIN
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
EP2117620A4 (en) * 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
EP2097115B1 (en) * 2006-11-13 2017-01-25 Elastagen Pty Ltd Use of tropoelastin for repair or restoration of tissue
US20090136438A1 (en) 2007-07-25 2009-05-28 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
JP2009039401A (ja) * 2007-08-10 2009-02-26 Extra Cellular Matrix Laboratories 綿状エラスチン架橋体の製造方法
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
WO2009099570A2 (en) 2008-02-01 2009-08-13 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
FR2926997B1 (fr) 2008-02-04 2012-06-29 Bernard Hertzog Aiguilles souples fines pour injection sous cutanee sans douleur
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
BRPI1009422B1 (pt) 2009-03-10 2019-10-01 Elastagen Pty Ltd Biomateriais injetáveis
WO2010110067A1 (ja) * 2009-03-27 2010-09-30 株式会社マルハニチロ食品 エラスチン及びコラーゲンを用いた架橋物及びその用途
PT2550027T (pt) 2010-03-22 2016-08-12 Allergan Inc Hidrogéis reticulados à base de polissacáridos e proteínopolissacáridos para aumento dos tecidos moles
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
AU2011334599B2 (en) 2010-11-23 2016-12-01 Allergan Pharmaceuticals International Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
HUE060291T2 (hu) 2011-09-30 2023-02-28 Allergan Pharmaceuticals Int Ltd Rugalmas rost in vivo szintézise
US9114128B2 (en) 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
AU2014306362B2 (en) 2013-08-13 2019-04-18 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
KR20160055940A (ko) 2013-09-24 2016-05-18 엘라스타겐 피티와이 리미티드 단백질 추출 방법

Also Published As

Publication number Publication date
RU2668877C2 (ru) 2018-10-04
US20200345892A1 (en) 2020-11-05
AU2013360011A1 (en) 2015-07-02
EP3449955A1 (en) 2019-03-06
KR20210042416A (ko) 2021-04-19
BR112015013627A2 (pt) 2017-07-11
US20160067741A1 (en) 2016-03-10
EP2928512B1 (en) 2018-08-15
JP2021072890A (ja) 2021-05-13
JP2016501084A (ja) 2016-01-18
KR20160002672A (ko) 2016-01-08
US11077226B2 (en) 2021-08-03
US20210353825A1 (en) 2021-11-18
EP3449955B1 (en) 2020-12-02
RU2015125182A (ru) 2017-01-12
DK2928512T3 (da) 2018-12-10
ES2702602T3 (es) 2019-03-04
JP6401178B2 (ja) 2018-10-03
AU2013360011B2 (en) 2017-02-02
KR102239867B1 (ko) 2021-04-13
CN105246520B (zh) 2017-11-21
ES2860023T3 (es) 2021-10-04
KR102398811B1 (ko) 2022-05-16
JP2018203768A (ja) 2018-12-27
EP2928512A4 (en) 2016-09-07
CN105246520A (zh) 2016-01-13
EP3821918A1 (en) 2021-05-19
CA2933047A1 (en) 2014-06-19
WO2014089610A1 (en) 2014-06-19
US10842913B2 (en) 2020-11-24
EP2928512A1 (en) 2015-10-14

Similar Documents

Publication Publication Date Title
DK3449955T3 (da) Fremstilling af skalerbart tredimensionelt elastisk konstrukt
DK3336097T3 (da) Fremstilling af ikke-krystallinsk obeticholsyre
DK3725778T3 (da) Formuleringer af enzalutamid
DK2845905T3 (da) Fremstilling af oligosaccharider
DK3235824T3 (da) Blanding af rp/sp gemcitabin-[phenyl-(benzyloxy-l-alaninyl)]-phosphat
DK3410737T3 (da) Skalerbar optisk koblingsnode
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
DK2961388T3 (da) Kombinationer af lægemidler
DK3293183T3 (da) Hæmmerforbindelser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
BR112014029111A2 (pt) inalador
DK2822568T3 (da) Anvendelser af caseinsammensætninger
DK2733803T4 (da) Sektion af kabelbakke
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
DK2936306T3 (da) Generering af en brugertilpasset anvendelse
DK2965026T3 (da) Generering af slushice
DK2934134T3 (da) Anvendelser af acetylsalicylsyreinhalering
DK2852392T3 (da) Anvendelser af ikke-sulfateret chondroitin
DK2838850T3 (da) Oprensning af titantetrachlorid
DK2916922T3 (da) Behandling af alkalisk bauxitrest
DE112013006162A5 (de) Schwingungsdämpfer
DK2928896T3 (da) Fast form af dihydro-pyrido-oxazin-derivat
DK2731573T3 (da) Forbedringer af indgivelsesanordninger
DK2820042T3 (da) Igg-stimuleret remyelinisering af perifere nerver